The origins of pharmaBank date back to 1995 when the company’s founding principals recognized Australia’s competitive advantages in therapeutic drug development.  Such advantages include a strong medical science community, extensive R & D facilities and well developed clinical trial capability married to an affordable pricing regime.  To capitalize on these advantages pharmaBank actively engaged in the international sourcing of life science projects to develop in Australia.